It’s possible that I shall make an ass of myself. But in that case one can always get out of it with a little dialectic. I have, of course, so worded my proposition as to be right either way (K.Marx, Letter to F.Engels on the Indian Mutiny)
Thursday, November 03, 2022
Volunteers in COVID-19 human challenge trials are genuinely altruistic, not desperate for money or lacking understanding of the risks
IMAGE: SELECTIONS WERE NOT RANKED, AND TOTAL PERCENTAGES ADD TO 300% BECAUSE EACH PARTICIPANT SELECTED 3 OPTIONS. THE TWO MOST COMMONLY SELECTED OPTIONS WERE “I WANTED TO HELP OTHERS AND POTENTIALLY SAVE LIVES” (95.9%) AND “I WANTED TO CONTRIBUTE TO THE PROGRESS OF MEDICINE” (79.2%).view more
CREDIT: MARSH ET AL., 2022, PLOS ONE, CC-BY 4.0 (HTTPS://CREATIVECOMMONS.ORG/LICENSES/BY/4.0/)
Article Title: Characterizing altruistic motivation in potential volunteers for SARS-CoV-2 challenge trials
Author Countries: USA, UK
Funding: This study was supported by 1Day Sooner in the form of a grant as part of the Open Philanthropy Project, and in the form of salaries for authors SMR, VS, & JM. This study was also supported by 1Day Sooner in the form of additional financial support for MP. The specific roles of these authors are articulated in the ‘author contributions’ section. This study was also supported by National Science Foundation in the form of grants for MM, NE (2039320) and AAM (1729406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Participants in volunteer and control groups were surveyed on their engagement with a range of altruistic behaviors, including blood donation, significant charitable donations and organ/marrow donor status. (IMAGE)
PLOS
CAPTION
Volunteers were significantly more likely than controls to have participated in all but one of the altruistic behaviors.
CREDIT
Marsh et al., 2022, PLOS ONE, CC-BY 4.0 (https://creativecommons.org/licenses/by/4.0/)
Characterizing altruistic motivation in potential volunteers for SARS-CoV-2 challenge trials
ARTICLE PUBLICATION DATE
2-Nov-2022
COI STATEMENT
The authors have read the journal’s policy and have the following competing interests: SMR and VS were employees of 1Day Sooner at the time of this study. JM is a current employee of 1Day Sooner. NE and AAM are on the Board of Advisors for 1Day Sooner. This does not alter our adherence to PLOS ONE policies on sharing data and materials. There are no patents, products in development or marketed products associated with this research to declare.
No comments:
Post a Comment